FDA Rejects Apricus Biosciences' Erectile Dysfunction Cream Vitaros Post author:Sam Post published:February 15, 2018 Post category:BioPharma The CRL indicates that the FDA cannot approve the NDA for Vitaros in its present form. Source: BioSpace You Might Also Like <b>Oscar</b> Winner Turned Pharma CEO: We???ll Prevent Genital Herpes March 7, 2017 Prolacta Bioscience To Present At The 2017 Conference On February 22, 2017 February 21, 2017 Lysogene Pushes Forward With Sanfilippo Syndrome Study, Establishes Footprint in U.S. October 24, 2017
Lysogene Pushes Forward With Sanfilippo Syndrome Study, Establishes Footprint in U.S. October 24, 2017